Solid Biosciences (SLDB) Depreciation & Amortization (CF) (2024 - 2026)

Solid Biosciences has reported Depreciation & Amortization (CF) for 10 years, with the latest figure at $395000.0 in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 2.95% year-over-year to $395000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 35.94% YoY) and the FY2025 annual result came in at $1.6 million, down 33.36% from the prior year.
• Depreciation & Amortization (CF) fell to $395000.0 in Q1 2026 per SLDB's latest filing, from $467000.0 in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $1.2 million in Q2 2024 and troughed at $327000.0 in Q1 2024.
• A 5-year average of $557352.9 and a median of $488000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) soared 75.68% in 2024, then slumped 68.74% in 2025.
• Over 5 years, Depreciation & Amortization (CF) stood at $539000.0 in 2022, then gained by 8.91% to $587000.0 in 2023, then slipped by 16.87% to $488000.0 in 2024, then decreased by 4.3% to $467000.0 in 2025, then decreased by 15.42% to $395000.0 in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $395000.0, $467000.0, and $376000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.